Similar findings were observed in apoptosis assays, wherein A549/PAX6 tumor cells exhibited a lower rate of apoptosis and were resistant to CDDP treatment (Fig. 3g; Additional file 1, Fig. S4b). Here, PAX6 is linked to neoplasm.